2796 related articles for article (PubMed ID: 7567787)
1. Biologic, immunocytochemical, and cytogenetic characterization of two new human melanoma cell lines: IIB-MEL-LES and IIB-MEL-IAN.
Kairiyama C; Slavutsky I; Larripa I; Morvillo V; Bravo AI; Bover L; Podhajcer OL; Mordoh J
Pigment Cell Res; 1995 Jun; 8(3):121-31. PubMed ID: 7567787
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptors in human melanoma cell lines IIB-MEL-LES and IIB-MEL-IAN and in human melanoma metastases.
Morvillo V; Lüthy IA; Bravo AI; Capurro MI; Portela P; Calandra RS; Mordoh J
Melanoma Res; 2002 Dec; 12(6):529-38. PubMed ID: 12459642
[TBL] [Abstract][Full Text] [Related]
3. Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.
Schadendorf D; Fichtner I; Makki A; Alijagic S; Küpper M; Mrowietz U; Henz BM
Br J Cancer; 1996 Jul; 74(2):194-9. PubMed ID: 8688321
[TBL] [Abstract][Full Text] [Related]
4. Two cell lines established from mixed müllerian tumors of the uterus. Morphologic, immunocytochemical, and cytogenetic analyses.
Emoto M; Iwasaki H; Kikuchi M; Ishiguro M; Kubota T; Izumi H; Shirakawa K; Kaneko Y
Cancer; 1992 Apr; 69(7):1759-68. PubMed ID: 1312893
[TBL] [Abstract][Full Text] [Related]
5. Characterization of IIB-MEL-J: a new and highly heterogenous human melanoma cell line.
Guerra L; Mordoh J; Slavutsky I; Larripa I; Medrano EE
Pigment Cell Res; 1989; 2(6):504-9. PubMed ID: 2602342
[TBL] [Abstract][Full Text] [Related]
6. Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice.
Van Muijen GN; Cornelissen LM; Jansen CF; Figdor CG; Johnson JP; Bröcker EB; Ruiter DJ
Clin Exp Metastasis; 1991; 9(3):259-72. PubMed ID: 2060184
[TBL] [Abstract][Full Text] [Related]
7. Approaches to prove the melanoma origin in amelanotic human melanoma cell lines.
Blasko M; Chalupa I; Borovanský J; Toceková M; Siracký J
Neoplasma; 1996; 43(6):411-5. PubMed ID: 8996567
[TBL] [Abstract][Full Text] [Related]
8. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system.
Pietsch T; Scharmann T; Fonatsch C; Schmidt D; Ockler R; Freihoff D; Albrecht S; Wiestler OD; Zeltzer P; Riehm H
Cancer Res; 1994 Jun; 54(12):3278-87. PubMed ID: 8205550
[TBL] [Abstract][Full Text] [Related]
9. Expression of cathepsin D in primary and metastatic human melanoma and dysplastic nevi.
Podhajcer OL; Bover L; Bravo AI; Ledda MF; Kairiyama C; Calb I; Guerra L; Capony F; Mordoh J
J Invest Dermatol; 1995 Mar; 104(3):340-4. PubMed ID: 7860998
[TBL] [Abstract][Full Text] [Related]
10. The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma.
Ledda F; Bravo AI; Adris S; Bover L; Mordoh J; Podhajcer OL
J Invest Dermatol; 1997 Feb; 108(2):210-4. PubMed ID: 9008236
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of HLA-DR gene expression induced by IFN-gamma in malignant melanoma cell lines.
Lee JL; Kim YH; Lee JM; Kim JD; Kim SJ; Park JH
Yonsei Med J; 1999 Feb; 40(1):30-9. PubMed ID: 10198604
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a 14 kDa immunosuppressive protein derived from IIB-MEL-J, a human melanoma cell line.
Morvillo V; Bover L; Mordoh J
Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):779-95. PubMed ID: 8832109
[TBL] [Abstract][Full Text] [Related]
13. Multiple karyotypic abnormalities, including structural rearrangements of 11p, in cell lines from malignant melanomas.
Heim S; Mandahl N; Arheden K; Giovanella BC; Yim SO; Stehlin JS; Mitelman F
Cancer Genet Cytogenet; 1988 Oct; 35(1):5-20. PubMed ID: 3180009
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a new human epithelioid sarcoma cell line, FU-EPS-1: molecular cytogenetic characterization by use of spectral karyotyping and comparative genomic hybridization.
Nishio J; Iwasaki H; Nabeshima K; Ishiguro M; Naumann S; Isayama T; Naito M; Kaneko Y; Kikuchi M; Bridge JA
Int J Oncol; 2005 Aug; 27(2):361-9. PubMed ID: 16010416
[TBL] [Abstract][Full Text] [Related]
15. Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.
Shimizu Y; Demetris AJ; Gollin SM; Storto PD; Bedford HM; Altarac S; Iwatsuki S; Herberman RB; Whiteside TL
Int J Cancer; 1992 Sep; 52(2):252-60. PubMed ID: 1355757
[TBL] [Abstract][Full Text] [Related]
16. Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6.
Miele ME; Robertson G; Lee JH; Coleman A; McGary CT; Fisher PB; Lugo TG; Welch DR
Mol Carcinog; 1996 Apr; 15(4):284-99. PubMed ID: 8634087
[TBL] [Abstract][Full Text] [Related]
17. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
Carrel S; Schreyer M; Gross N; Zografos L
Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
[TBL] [Abstract][Full Text] [Related]
18. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection.
Lehmann F; Marchand M; Hainaut P; Pouillart P; Sastre X; Ikeda H; Boon T; Coulie PG
Eur J Immunol; 1995 Feb; 25(2):340-7. PubMed ID: 7875194
[TBL] [Abstract][Full Text] [Related]
19. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.
Weber J; Salgaller M; Samid D; Johnson B; Herlyn M; Lassam N; Treisman J; Rosenberg SA
Cancer Res; 1994 Apr; 54(7):1766-71. PubMed ID: 7511051
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of human vaginal malignant melanoma xenotransplants.
Sawada M; Terada N; Nishizawa Y; Ito S; Wakamatsu K; Takemura K; Yamamoto T; Ozaki M; Sakamoto H; Tanizawa O
Anticancer Res; 1994; 14(4A):1477-82. PubMed ID: 7526770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
